Recent Finacing
Recent Raise
Santaris Pharma is a Danish biotech developing antisense gene‑silencing therapeutics using locked nucleic acid–DNA oligonucleotides to bind mRNA, targeting CLL with clinical and preclinical programs and licensing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
